Guidance for Industry: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2); Availability, 76463 [E5-7803]

Download as PDF Federal Register / Vol. 70, No. 247 / Tuesday, December 27, 2005 / Notices does not cause an allergic response that poses a risk to human health or if it does not contain allergenic protein. FALPCA’s labeling requirements apply to products labeled on or after January 1, 2006. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005D–0490] Guidance for Industry: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2); Availability AGENCY: Food and Drug Administration, HHS. Notice of availability of guidance. ACTION: bjneal on PROD1PC70 with NOTICES SUMMARY: The Food and Drug Administration (FDA) is announcing the availability of a revised guidance document entitled ‘‘Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2).’’ The guidance explains, using a question and answer format, FDA’s current thinking on a number of issues related to the regulation of food allergens, including implementation of the Food Allergen Labeling and Consumer Protection Act (FALCPA). DATES: Submit written or electronic comments on the guidance document at any time. ADDRESSES: Submit written comments on the guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to https:// www.fda.gov/dockets/ecomments. See the SUPPLEMENTARY INFORMATION section for electronic access to the guidance document. FOR FURTHER INFORMATION CONTACT: Rhonda R. Kane, Center for Food Safety and Applied Nutrition (HFS–820), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301–436–2371, or e-mail: rhonda.kane@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The FALCPA (Public Law 108–282) amends the Federal Food, Drug, and Cosmetic Act and requires that the label of a food product that is or contains an ingredient that bears or contains a ‘‘major food allergen’’ declare the presence of the allergen as specified by FALCPA. FALCPA defines a ‘‘major food allergen’’ as one of eight foods or a food ingredient that contains protein derived from one of those foods. A food ingredient may be exempt from FALCPA’s labeling requirements if it VerDate Aug<31>2005 14:54 Dec 23, 2005 Jkt 208001 II. Discussion FDA has received numerous questions about the application of FALCPA’s requirements to food products. To explain FALCPA’s requirements as well as FDA’s current thinking on several issues relating to the regulation of food allergens, on October 5, 2005, FDA posted the first edition of a guidance entitled ‘‘Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004’’ on the agency’s Web site at https://www.cfsan.fda.gov/~dms/ alrguid.html. The guidance that is the subject of this notice, ‘‘Guidance for Industry: Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)’’ is a revision of the guidance posted on October 5, 2005, and responds to additional questions about FALCPA and food allergens. The revised guidance is intended to share with industry FDA’s current thinking on the additional questions presented in the guidance. Given the nature of the revisions to the guidance, FDA is issuing the guidance as a level 1 guidance. Consistent with FDA’s good guidance practices regulation (§ 10.115 (21 CFR 10.115)), the agency will accept comments, but it is implementing the guidance document immediately, in accordance with § 10.115(g)(2), because the agency has determined that prior public participation is not feasible or appropriate. As noted, FALPCA’s labeling requirements apply to products labeled on or after January 1, 2006. Clarifying FDA’s current thinking on the additional issues presented by FALCPA’s implementation will help facilitate the food industry’s compliance with FALCPA’s requirements. FDA expects to continue to receive a large number of questions regarding the implementation of FALCPA and the regulation of food allergens generally. The agency intends to respond to these inquires under § 10.115 as promptly as possible, using a question and answer format. The agency believes that, at the present time, it is reasonable to maintain all responses to questions concerning food allergens and FALCPA in a single document that is periodically updated as the agency receives and responds to additional questions. The following four indicators will be PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 76463 employed to help users of the guidance identify revisions: (1) The guidance will be identified as a revision of a previously issued document, (2) the revision date of the guidance will appear on its cover, (3) the edition number of the guidance will be included in its title, and (4) questions and answers that have been added to the original guidance will be identified as such in the body of the guidance. This guidance represents the agency’s current thinking on issues related to FALCPA and food allergens generally that are presented in the guidance. The guidance does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. III. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) written or electronic comments regarding this guidance at any time. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The guidance and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. V. Electronic Access Persons with access to the Internet may obtain the guidance document at https://www.cfsan.fda.gov/~dms/ alrguid2.html. Other information about food allergens may be obtained at https:// www.cfsan.fda.gov/~dms/whalrgy.html. Dated: December 16, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E5–7803 Filed 12–23–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization, Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) (60 FR E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 70, Number 247 (Tuesday, December 27, 2005)]
[Notices]
[Page 76463]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-7803]



[[Page 76463]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2005D-0490]


Guidance for Industry: Questions and Answers Regarding Food 
Allergens, Including the Food Allergen Labeling and Consumer Protection 
Act of 2004 (Edition 2); Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability of guidance.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
availability of a revised guidance document entitled ``Guidance for 
Industry: Questions and Answers Regarding Food Allergens, including the 
Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 
2).'' The guidance explains, using a question and answer format, FDA's 
current thinking on a number of issues related to the regulation of 
food allergens, including implementation of the Food Allergen Labeling 
and Consumer Protection Act (FALCPA).

DATES: Submit written or electronic comments on the guidance document 
at any time.

ADDRESSES: Submit written comments on the guidance to the Division of 
Dockets Management (HFA-305), Food and Drug Administration, 5630 
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments 
to https://www.fda.gov/dockets/ecomments. See the SUPPLEMENTARY 
INFORMATION section for electronic access to the guidance document.

FOR FURTHER INFORMATION CONTACT: Rhonda R. Kane, Center for Food Safety 
and Applied Nutrition (HFS-820), Food and Drug Administration, 5100 
Paint Branch Pkwy., College Park, MD 20740, 301-436-2371, or e-mail: 
rhonda.kane@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The FALCPA (Public Law 108-282) amends the Federal Food, Drug, and 
Cosmetic Act and requires that the label of a food product that is or 
contains an ingredient that bears or contains a ``major food allergen'' 
declare the presence of the allergen as specified by FALCPA. FALCPA 
defines a ``major food allergen'' as one of eight foods or a food 
ingredient that contains protein derived from one of those foods. A 
food ingredient may be exempt from FALCPA's labeling requirements if it 
does not cause an allergic response that poses a risk to human health 
or if it does not contain allergenic protein. FALPCA's labeling 
requirements apply to products labeled on or after January 1, 2006.

II. Discussion

    FDA has received numerous questions about the application of 
FALCPA's requirements to food products. To explain FALCPA's 
requirements as well as FDA's current thinking on several issues 
relating to the regulation of food allergens, on October 5, 2005, FDA 
posted the first edition of a guidance entitled ``Guidance for 
Industry: Questions and Answers Regarding Food Allergens, including the 
Food Allergen Labeling and Consumer Protection Act of 2004'' on the 
agency's Web site at https://www.cfsan.fda.gov/~dms/alrguid.html. The 
guidance that is the subject of this notice, ``Guidance for Industry: 
Questions and Answers Regarding Food Allergens, including the Food 
Allergen Labeling and Consumer Protection Act of 2004 (Edition 2)'' is 
a revision of the guidance posted on October 5, 2005, and responds to 
additional questions about FALCPA and food allergens. The revised 
guidance is intended to share with industry FDA's current thinking on 
the additional questions presented in the guidance.
    Given the nature of the revisions to the guidance, FDA is issuing 
the guidance as a level 1 guidance. Consistent with FDA's good guidance 
practices regulation (Sec.  10.115 (21 CFR 10.115)), the agency will 
accept comments, but it is implementing the guidance document 
immediately, in accordance with Sec.  10.115(g)(2), because the agency 
has determined that prior public participation is not feasible or 
appropriate. As noted, FALPCA's labeling requirements apply to products 
labeled on or after January 1, 2006. Clarifying FDA's current thinking 
on the additional issues presented by FALCPA's implementation will help 
facilitate the food industry's compliance with FALCPA's requirements.
    FDA expects to continue to receive a large number of questions 
regarding the implementation of FALCPA and the regulation of food 
allergens generally. The agency intends to respond to these inquires 
under Sec.  10.115 as promptly as possible, using a question and answer 
format. The agency believes that, at the present time, it is reasonable 
to maintain all responses to questions concerning food allergens and 
FALCPA in a single document that is periodically updated as the agency 
receives and responds to additional questions. The following four 
indicators will be employed to help users of the guidance identify 
revisions: (1) The guidance will be identified as a revision of a 
previously issued document, (2) the revision date of the guidance will 
appear on its cover, (3) the edition number of the guidance will be 
included in its title, and (4) questions and answers that have been 
added to the original guidance will be identified as such in the body 
of the guidance.
    This guidance represents the agency's current thinking on issues 
related to FALCPA and food allergens generally that are presented in 
the guidance. The guidance does not create or confer any rights for or 
on any person and does not operate to bind FDA or the public. An 
alternative approach may be used if such approach satisfies the 
requirements of the applicable statutes and regulations.

III. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) written or electronic comments regarding this guidance 
at any time. Submit a single copy of electronic comments or two paper 
copies of any mailed comments, except that individuals may submit one 
paper copy. Comments are to be identified with the docket number found 
in brackets in the heading of this document. The guidance and received 
comments may be seen in the Division of Dockets Management between 9 
a.m. and 4 p.m., Monday through Friday.

V. Electronic Access

    Persons with access to the Internet may obtain the guidance 
document at https://www.cfsan.fda.gov/~dms/alrguid2.html. Other 
information about food allergens may be obtained at https://
www.cfsan.fda.gov/~dms/wh-alrgy.html.

    Dated: December 16, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E5-7803 Filed 12-23-05; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.